Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00482417

Enrollment

Registered

2007-06-05

Start date

2002-12-31

Completion date

2003-05-31

Last updated

2015-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

Efficacy and Safety Study of MK0359 in Patients with Arthritis

Interventions

DRUGMK0359

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* You are 18-65 years of age and have Rheumatoid Arthritis * You must be able to read and understand patient questionnaires

Exclusion criteria

* You have had certain types of surgery, certain types of cancer or history of Tuberculosis (TB) or HIV.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026